Development and validation of high resolution melting assays for high-throughput screening of BDNF rs6265 and DAT1 rs40184

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Full Genotyping of a Highly Polymorphic Human Gene Trait by Time-Resolved Fluorescence Resonance Energy Transfer

  2014cited by this paper
• Mechanisms of dopamine transporter regulation in normal and disease states.

  2013cited by this paper
• Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders

  2012cited by this paper
• Restriction Fragment Length Polymorphism Analysis of PCR-Amplified Fragments (PCR-RFLP) and Gel Electrophoresis - Valuable Tool for Genotyping and Genetic Fingerprinting

  2012cited by this paper
• Association of C/T polymorphism in intron 14 of the dopamine transporter gene (rs40184) with major depression in a northeastern Thai population.

  2010cited by this paper
• High-resolution DNA melting analysis in clinical research and diagnostics

  2010cited by this paper
• Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A

  2010cited by this paper
• Assessing high‐resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments

  2009cited by this paper
• Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.

  2009cited by this paper
• Effects of the Brain-Derived Neurotrophic Growth Factor Val66Met Variation on Hippocampus Morphology in Bipolar Disorder

  2009cited by this paper
• Interaction between BDNF and Serotonin: Role in Mood Disorders

  2008cited by this paper
• High resolution melting applications for clinical laboratory medicine.

  2008cited by this paper
• Role of the brain‐derived neurotrophic factor at glutamatergic synapses

  2008cited by this paper
• Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD

  2008cited by this paper
• Association Between Polymorphisms in the Dopamine Transporter Gene and Depression

  2008cited by this paper
• The functional impact of SLC6 transporter genetic variation.

  2007cited by this paper
• The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.

  2006cited by this paper
• BDNF gene variants and brain morphology in schizophrenia

  2006cited by this paper
• Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease

  2006cited by this paper
• Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation

  2005cited by this paper
• The American Psychiatric Association

  2005cited by this paper
• Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons.

  2004cited by this paper
• Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons

  2004cited by this paper
• High-resolution genotyping by amplicon melting analysis using LCGreen.

  2003cited by this paper
• The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

  2003cited by this paper
• Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes.

  2003cited by this paper
• Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

  2003cited by this paper
• Association Study of a Brain-Derived Neurotrophic-Factor Genetic Polymorphism and Mood Disorders, Age of Onset and Suicidal Behavior

  2003cited by this paper
• Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.

  2001cited by this paper
• Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

  2001cited by this paper
• Hyperactivity and impaired response habituation in hyperdopaminergic mice.

  2001cited by this paper
• Trk receptors: mediators of neurotrophin action.

  2001cited by this paper
• Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

  2000cited by this paper
• Functional hyperdopaminergia in dopamine transporter knock-out mice.

  1999cited by this paper
• Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

  1999cited by this paper
• Association of attention-deficit disorder and the dopamine transporter gene.

  1995cited by this paper
• Detection and localization of single base changes by denaturing gradient gel electrophoresis.

  1987cited by this paper
• Theme and variations

  1956cited by this paper

• Association of HHV‑6 reactivation and SLC6A3 (C>T, rs40184), BDNF (C>T, rs6265), and JARID2 (G>A, rs9383046) single nucleotide polymorphisms in depression

  2024cites this paper
• Predictors of recurrence of major depressive disorder

  2020cites this paper
• Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients

  2019cites this paper
• Dopamine transporter 1 (DAT1) rs40184 single nucleotide polymorphism is not associated with the Malaysian major depressive disorder subjects

  2019cites this paper
• Development of High-resolution Melting Assays for the Detection of Single Nucleotide Polymorphisms in Iron-related Genes: The Food and Nutrition Research Institute’s Nutritional Genomics Laboratory Experience

  2019cites this paper